Xbrane Biopharma AB
Per Edebrink began their work experience in 2001 as a Team Manager at AstraZeneca. Per worked in this role until 2006, at which point they joined AstraZeneca as an Associated Scientist. In 2009, Edebrink moved on to Cobra Biologics where they held the position of Principal Scientist, specifically as the Analytical lead responsible for strategic decisions in Analytical development and Product characterization studies. In 2018, Edebrink joined Xbrane Biopharma AB as the Head of Analytics.
Per Edebrink completed their education in the field of Organic Chemistry at Stockholm University. Per obtained a Bachelor of Science degree from Stockholm University between 1984 and 1987. Following this, they pursued further studies and earned a Doctor of Philosophy (PhD) degree in Organic Chemistry from Stockholm University, completing their doctoral education between 1989 and 1995.
This person is not in any offices
Xbrane Biopharma AB
Xbrane is a biopharmaceutical company specialized in high demand complex generics.The segment have a high entry barrier, driven by high production complexity and the need of specific Know-How. Xbrane currently possess it own expertise within production of complex generics with slow release formulation and unique technologies for producing Proteinsefficiently.